Ϫ/Ϫ mice were ϳ35 mmHg more hypertensive than WT mice at both 8 -12 wk (young adult) and 20 -24 wk (mature mice, P Ͻ 0.01; n ϭ 8 -10). Endothelium-dependent relaxations of the thoracic aorta were evaluated by isometric myography after contraction with phenylephrine (10 Ϫ6 M). Maximal ACh-dependent relaxations were increased from 65 Ϯ 1% to 73 Ϯ 1% in the aorta from young adult (P Ͻ 0.01; n ϭ 6) and from 45 Ϯ 1% to 74 Ϯ 1% in the aorta from mature (P Ͻ 0.001; n ϭ 5) K 2P6.1 Ϫ/Ϫ mice compared with K2P6.1 ϩ/ϩ littermates. However, in the aorta from young adult and mature K2P6.1 ϩ/ϩ mice, 10 Ϫ5 M indomethacin, a cyclooxygenase inhibitor, increased maximal ACh relaxations to knockout levels. Enhanced relaxation was also seen with ATP, a P2Y purinergic agonist, and A23187, a nonreceptor-based agonist in mature K2P6.1 Ϫ/Ϫ mice. Mature adult aorta from K 2P6.1 Ϫ/Ϫ showed an attenuated AChmediated contraction in the presence of nitro-L-arginine methyl ester (L-NAME) and without precontraction of 0.97 mN vs. 7.5 mN in K2P6.1 Ϫ/Ϫ and K2P6.1 ϩ/ϩ (P Ͻ 0.001; n ϭ 5). In summary, K2P6.1 Ϫ/Ϫ mice, which are hypertensive, have enhanced endothelium-dependent relaxations in the aorta due to the suppression of an indomethacin-sensitive constrictor component.
TWO-PORE DOMAIN POTASSIUM channels (K 2P ) are a recently discovered family of K channels that are ubiquitously expressed. Of the 15 gene members in the K 2P family (gene name KCNK), more than half of the members are expressed in the vasculature, with K 2P 2.1 (TREK-1), K 2P 3.1 (TASK-1), and K 2P 6.1 (TWIK-2) being highly expressed (18) . The function of these K 2P members in vascular smooth muscle is not fully understood, although recent studies have attempted to clarify their role in regulating vascular tone (4, 16, 23, 26, 36) . We recently showed that gene deletion of K 2P 6.1 resulted in vascular smooth muscle cell depolarization, altered aortic function, increased peripheral vascular resistance, and hypertension in 8 -12-wk-old male mice (23) . These initial studies in the K 2P 6.1-deficient mice (K 2P 6.1 Ϫ/Ϫ ) focused on vascular smooth muscle. However, K 2P 6.1 is expressed not only in the vascular smooth muscle but also in the endothelium (23) . It is not known whether the lack of K 2P 6.1 in the endothelium is involved with altered aortic function in K 2P 6.1 Ϫ/Ϫ mice. This issue is especially important since attenuations in endotheliumdependent relaxations [primarily through nitric oxide (NO)] are closely associated with hypertension (12, 13, 37) .
The purpose of this study was to determine whether endothelium-dependent relaxations in the aorta contribute to vascular dysfunction in young adult (8 -12 wk) and mature (20 -24 wk) K 2P 6.1 Ϫ/Ϫ mice. If the endothelium is involved with the hypertension, we predict that endothelium-dependent relaxations (primarily NO) would be attenuated.
MATERIALS AND METHODS
All studies were approved by the Institutional Animal Care and Use Committee at the Baylor College of Medicine. K 2P6. 1 Ϫ/Ϫ animals were created and maintained on a C57BL6-SV129 hybrid background, as previously described (23) . Male F1 hybrid littermate controls were used for this study. Studies were conducted on young adult (8 -12 wk) and mature (20 -24 wk) mice.
Blood pressure was measured using either tail cuff plethysmography or telemetry after implantation of a catheter in the carotid artery. For tail cuff plethysmography, mice were trained to enter a restraining tube on five successive days. On the fifth day, several plethysmograph readings were obtained and averaged.
For other mice, blood pressure was measured using a telemeter system (PA-C10; Data Science International). Two hours prior to the surgery, the mice received ketoprofen (10 mg/kg sc) as an analgesic. The mice were anesthetized with 2% isoflurane in O 2, and a blood pressure catheter was inserted into the right carotid artery. The telemeter device was placed subcutaneously in the abdomen. Once the surgery was complete, the mice were allowed to recover for 7 days. On day 8, blood pressure was continuously recorded for a 24-h period.
Changes in force generated by aortic segments were measured using wire myography, as previously described (23) . Segments were allowed to equilibrate in Krebs buffer (gassed with 5% CO 2/21% O 2/balance N2) for 1 h at 37°C, and then adjusted to the resting tension of 1.2 mN. Each segment was contracted three times with 40 mM hypertonic KCl followed by one 60 mM hypertonic KCl contraction prior to each experiment. Some segments were precontracted with 10 Ϫ6 M phenylephrine (EC80) prior to relaxation. Aortic contractions to PE were similar between K 2P6.1 ϩ/ϩ and K2P6.1 Ϫ/Ϫ mice, as shown in previous studies (23) . Contraction values for phenylephrine were 9.9 Ϯ 1.4 and 8.4 Ϯ 1.6 mN for WT and KO (P ϭ 0.48; n ϭ 5) in young adult and 13.3 Ϯ 2.5 and 11.3 Ϯ 0.7 mN for WT and KO (P ϭ 0.46; n ϭ 4) in mature K 2P6.1 mice, respectively. Furthermore, the effects of PE with the addition of the blockers L-NAME, indomethacin, and tiron were no different between genotype. The EC 50 and the maximum effect were calculated using Sigma ϪHillslope ]. For histological analysis, aortic segments were fixed in 10% neutral buffered formalin, paraffin-embedded, sectioned at 5 m, and stained with the Movat method, as previously described (23) . A Zeiss Axioplan II upright microscope was used to capture bright-field images.
Values are expressed as means Ϯ SE and the two-tailed unpaired t-test. The standard error of the least square means (SELSM) replaced the SE when repeated-measures (RM) two-way ANOVA with the post hoc Holm-Sidak test for multiple comparisons was used. The level of significance was set at P Ͻ 0.05.
RESULTS
Telemetry measurements of mean arterial blood pressure (MAP), systolic blood pressure (SBP), and heart rate (HR) in young adult (8 -12 ϩ/ϩ , while pulse pressure and cage activity were similar in the two genotypes (data not shown).
Next, we determined whether the hypertension progressed as the animals aged from young adult to maturity. We chose tail cuff plethysmography to measure consecutive SBP and HR over 12 wk in individual mice. Figure 2 shows significantly increased SBP in the young adult (ϩ29 mmHg) and mature (ϩ40 mmHg) K 2P 6.1 Ϫ/Ϫ mice compared with age-matched K 2P 6.1 ϩ/ϩ mice (Fig. 2, A and B, respectively) (P Ͻ 0.01; n ϭ 10). This indicates sustained systolic hypertension from 8 to 24 wk in the K 2P 6.1 Ϫ/Ϫ mice. Interestingly, there was no significant change in SBP between the young adult and mature K 2P 6.1 Ϫ/Ϫ mice, indicating lack of overt hypertension progression with maturation.
Since background strain affects blood pressure in various animal models (17, 19 , 31), we tested blood pressure by tail cuff plethysmography in mature (20 -24 wk) mice that were backcrossed on a C57 background for 10 generations. K 2P 6.1 deficiency on a C57 background showed increased SBP (ϩ29 mmHg) with no change in heart rate (P Ͻ 0.001; n ϭ 7, data not shown). This result indicates that the blood pressure effects of K 2P 6.1 deficiency were not dependent on the mixed background strain of the mice.
We then tested endothelium-dependent relaxations in aortic segments from K 2P 6.1 ϩ/ϩ and K 2P 6.1 Ϫ/Ϫ mice using wire myography. Young adult K 2P 6.1 Ϫ/Ϫ mice showed an increased maximal endothelium-dependent relaxation from 47 Ϯ 1% to 77 Ϯ 1% (P Ͻ 0.001; n ϭ 8) to carbachol, an ACh analog (Fig. 3A) , with a 21% leftward shift in the concentration response curve EC 50 , from 2.3 Ϯ 0.1 M in WT to 1.8 Ϯ 0.1 M in KO. Relaxations to carbachol were abolished in the presence of the nitric oxide synthase (NOS) inhibitor nitro-L-arginine methyl ester (L-NAME). Because enhanced relaxations can also result from increased sensitivity of the smooth muscle to NO itself (14), we performed a dose-response experiment to the NO donor, MAHMA NONOate, with and without L-NAME pretreatment. The aortic segments showed no difference in relaxation to MAHMA NONOate between genotypes, indicating that the enhanced endothelium-dependent relaxations in K 2P 6.1 Ϫ/Ϫ mice were not due to increased sensitivity of the smooth muscle to NO (Fig. 3B) .
We then characterized the enhanced endothelium-dependent relaxations of young adult aortic segments using ACh. Maximal relaxation to ACh was increased from 65 Ϯ 1% to 73 Ϯ 1% in the aorta from young adult (P Ͻ 0.01; n ϭ 6) K 2P 6 (Fig. 5A , P Ͻ 0.001; n ϭ 5). Preincubation with indomethacin enhanced the ACh-dependent relaxation in K 2P 6.1 ϩ/ϩ mice, making it similar to that in the K 2P 6.1 (Fig. 5A) . Analysis of the change in relaxation with age revealed that the K 2P 6.1 ϩ/ϩ showed a significant (P Ͻ 0.05; n ϭ 5) decrease from 63 Ϯ 1% to 45 Ϯ 1% in AChdependent relaxations from young adult to maturity (Fig.  5B) , while the K 2P 6.1 Ϫ/Ϫ mice had no change in AChdependent relaxations with age (Fig. 5C ). The relaxations in aortic segments from young adult and mature K 2P 6.1 Ϫ/Ϫ mice were similar in the presence or absence of indomethacin. In addition, the ACh-dependent relaxations of K 2P 6.1 Ϫ/Ϫ were similar to K 2P 6.1 ϩ/ϩ with indomethacin. We tested other agents that relax aortic segments through an endothelium-dependent mechanism. Relaxations to ATP, a P 2Y receptor agonist (Fig. 6A) were increased at 10 Ϫ4 M from 27 Ϯ 4% to 54 Ϯ 6% (P Ͻ 0.05; n ϭ 4), while relaxations to A23187, a Ca 2ϩ ionophore (Fig. 6C) , were increased at 10 M from 12 Ϯ 8% to 57 Ϯ 10% (P Ͻ 0.05; n ϭ 4) in aortic segments obtained from 20 -24-wk-old K 2P 6.1 ϩ/ϩ and K 2P 6.1 Ϫ/Ϫ mice, respectively. Indomethacin had little to no effect on the relaxations in segments from K 2P , we preincubated the aortic segments with 10 Ϫ5 M L-NAME and performed a dose-response experiment to ACh in the absence of PE contraction. This method has been used to exclusively study endotheliumdependent contracting factors without the inhibitory effects of NO on the contraction and in the suppression of NOS activity (38) . Mature adult aorta from K 2P 6.1 Ϫ/Ϫ showed an attenuated ACh-mediated contraction of 0.97 mN vs. 7.5 mN in K 2P 6.1 Ϫ/Ϫ and K 2P 6.1 ϩ/ϩ ( Fig. 7A , P Ͻ 0.01 RM ANOVA, P Ͻ 0.001 RM ANOVA interaction; n ϭ 5). This indicates that the K 2P 6.1 Ϫ/Ϫ had a largely suppressed endothelium-dependent contraction that was present in the K 2P 6.1 ϩ/ϩ . Furthermore, indomethacin abolished the contractions in both genotypes (Fig. 7B) .
Finally we performed a histological analysis on the aortic segments to assess for differences in morphology using Movat staining. We found no differences in medial thickness and luminal diameter in the mature K 2P 6.1 Ϫ/Ϫ vs. K 2P 6.1 ϩ/ϩ mice (Fig. 8) . Furthermore, on visual inspection, there was no obvious myocyte disarray or alterations in elastin or collagen organization.
DISCUSSION
The purpose of this study was to determine whether K 2P 6.1 Ϫ/Ϫ mice have impaired endothelium-dependent relaxations that would indicate endothelial dysfunction. Because endothelial dysfunction is associated with hypertension and often precedes its onset (13, 37) , it was reasonable to hypothesize that endothelial dysfunction (decreased endotheliumdependent relaxations) would occur in K 2P 6.1 Ϫ/Ϫ mice. Surprisingly, not only was there no attenuation of relaxations, but relaxations of the aorta by endothelium-dependent mechanisms were actually enhanced in K 2P 6.1 Ϫ/Ϫ mice (Figs. 3-6 ). It follows that endothelium dysfunction cannot account for the hypertension that we report in K 2P 6.1 Ϫ/Ϫ mice. The enhanced relaxations in aortas from young adult K 2P 6.1 Ϫ/Ϫ mice resulted from the suppression of an indomethacin-sensitive/ROS constrictor component, which was present in aortas from K 2P 6.1 ϩ/ϩ mice. In the young adult mice, the addition of the ROS scavenger, tiron, had no effect on relaxations in the K 2P 6.1 Ϫ/Ϫ aorta; however, it substantially enhanced relaxation in the K 2P 6.1 ϩ/ϩ (Fig. 4) at the doses of ACh Ͻ 10 Ϫ7 M. As the normal mice (i.e., K 2P 6.1 ϩ/ϩ ) mature (20 -24 wk), relaxations of the aorta to ACh decline (Fig. 5 ) through increased indomethacin-sensitive vasoactive prostanoids and ROS generated from cyclooxygenase reactions (1, 32, 37) . Interestingly, endothelium-dependent relaxations were not altered with maturation in the aorta from K 2P 6.1 Ϫ/Ϫ mice. In the aorta from young and mature adult mice, indomethacin was able to enhance relaxation in K 2P 6.1 ϩ/ϩ to that observed in K 2P 6.1 Ϫ/Ϫ mice. Our data would indicate that the difference in relaxations to ACh in K 2P 6.1 ϩ/ϩ and K 2P 6.1 Ϫ/Ϫ mice involves an indomethacin-sensitive/ROS constrictor component (Fig. 7) . It is noteworthy that our previous studies (23) in K 2P 6.1 Ϫ/Ϫ aortas showed greater, not less sensitivity, to the thromboxane prostanoid receptor agonist U46619 than K 2P 6.1 ϩ/ϩ , which rules out the possibility that the K 2P 6.1 Ϫ/Ϫ aortas are insensitive to at least some vasoactive prostanoids.
Hypertension is strongly associated with endothelial dysfunction in humans and animal models (5, 9, 24, 25, 34) . The extent of endothelial dysfunction appears related to the elevated blood pressures, as reversal of hypertension causes normalization of endothelial function, except in the presence of combined pathologies (39, 41) . Rescue of endothelial function with blood pressure control has been extensively documented in the human (3, 8, 20, 21, 35, 40) , rat (10, 11, 30) , and mouse (22, 33) . Our results demonstrate that attenuation of endothelium-dependent relaxations is not necessary for hypertension to occur. Furthermore, attenuation of endothelium-dependent relaxations does not necessarily result from hypertension. Thus, the mechanism of hypertension in the K 2P 6.1 Ϫ/Ϫ mice may be altogether independent of the endothelium.
Our results can be compared and contrasted to endothelial function in both the spontaneously hypertensive rat (SHR) and the borderline hypertensive rat (BHR). The SHR and the BHR showed a similar stage of indomethacin-insensitive enhanced endothelium-dependent relaxations to ACh (2, 6, 7, 15, 27, 28) and A23187 (27) . Enhanced endotheliumdependent relaxations occurred in young adult (6 wk) rats in the developing stages of hypertension only. By maturity (16 -20 wk) in the SHR, when significant hypertension occurred, there was marked indomethacin-sensitive endothelial dysfunction. In K 2P 6.1 Ϫ/Ϫ mice systolic blood pressure did not significantly progress from young adult to maturity (Fig. 2) , as with the SHR model. It is possible that the maintenance of enhanced endothelial relaxations in K 2P 6.1 Ϫ/Ϫ mice limited the progression of hypertension. It is also possible that the decreased indomethacin-sensitive/ ROS constrictor component allowed the K 2P 6.1 Ϫ/Ϫ mice to, thereby, "escape" the deleterious feedback loop between hypertension and endothelial dysfunction.
Although there are numerous possibilities as to why the aorta from K 2P 6.1 Ϫ/Ϫ mice do not have an indomethacinsensitive/ROS constrictor component, one point of speculation involves Ca 2ϩ regulation in the endothelium. The membrane potential is a determinant of the driving force for extracellular Ca 2ϩ to move into the cytoplasm of endothelium. The more hyperpolarized the membrane becomes, the greater the driving force for Ca 2ϩ to enter the endothelium. If the absence of 
Perspectives and Significance
We show that K 2P 6.1 Ϫ/Ϫ mice have enhanced endotheliumdependent relaxations in young adult and mature mice concomitant with significant systolic hypertension. The enhanced relaxations result from decreased synthesis of indomethacinsensitive/ROS constrictor components, which oppose NO. Studies on humans do not indicate that hypertension is associated with any period of overt adaptive or compensatory increases in endothelium-dependent relaxations. This study is the first to describe a model in which sustained hypertension is linked not to endothelial dysfunction but rather to endothelial "hyper"-function. It may be the endothelium itself is producing a compensatory response to hypertension, which limits its progression.
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